The general strike announced on Dec. 13 by Israeli Labor Union Chair Avi Nissenkorn, in response to the mass layoffs at Teva Pharmaceutical Industries, will not turn things around. The Israeli pharmaceutical giant is in a deep crisis, fighting for its life, and if it does not become more efficient and carry out aggressive rehabilitation steps, it will not be able to survive.
Nissenkorn knows this, as do the leaders of the powerful labor unions at the company plants in Israel. Yet on Dec. 17, Israel’s whole public sector, health services and banks ground to a halt from early morning until noon. Flights in and out of the country were also suspended. The cost of this strike is estimated at hundreds of millions of shekels.